Literature DB >> 675152

Urolithiasis in chronic inflammatory bowel disease.

L Knudsen, H Marcussen, P Fleckenstein, E B Pedersen, S Jarnum.   

Abstract

In a selected material of 228 patients with chronic inflammatory bowel disease (CIBD) the incidence of urolithiasis was 15% (95% confidence limit 11-21). The tendency to urolithiasis is significantly correlated to small-bowel resection and its extent and to obstruction in the urinary tract. On the other hand, there is no definite correlation to the duration or extent of the bowel disease. The significant correlation between urolithiasis and ileal resection is in agreement with the hyperabsorption of oxalate as an important cause of stone formation demonstrated by others. That local factors too play an essential role in the formation of urinary calculi is apparent from the increased incidence of urolithiasis in obstruction of the urinary tract. The incidence of urolithiasis was particularly high (22-25%) among patients with ileostomies. The few and negligible symptoms of and sequelae to, urolithiasis in CIBD encourage a conservative attitude.

Entities:  

Mesh:

Year:  1978        PMID: 675152     DOI: 10.3109/00365527809181917

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Metabolic disorders in patients with calcium urolithiasis.

Authors:  M Butz
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

2.  Prevention of uric acid stone formation by sodium bicarbonate in an ileostomy patient--a case report.

Authors:  T Fukushima; A Sugita; S Masuzawa; Y Yamazaki; H Takemura; S Tsuchiya
Journal:  Jpn J Surg       Date:  1988-07

3.  Prophylaxis of uric acid stone in patients with inflammatory bowel disease following extensive colonic resection.

Authors:  T Fukushima; Y Yamazaki; A Sugita; S Tsuchiya
Journal:  Gastroenterol Jpn       Date:  1991-08

Review 4.  Epidemiology and clinical pathophysiology of uric acid kidney stones.

Authors:  Khashayar Sakhaee
Journal:  J Nephrol       Date:  2014-02-05       Impact factor: 3.902

5.  Pathophysiology and Treatment of Enteric Hyperoxaluria.

Authors:  Celeste Witting; Craig B Langman; Dean Assimos; Michelle A Baum; Annamaria Kausz; Dawn Milliner; Greg Tasian; Elaine Worcester; Meaghan Allain; Melissa West; Felix Knauf; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 8.237

6.  Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.

Authors:  Stefania Fagagnini; Henriette Heinrich; Jean-Benoît Rossel; Luc Biedermann; Pascal Frei; Jonas Zeitz; Marianne Spalinger; Edouard Battegay; Lukas Zimmerli; Stephan R Vavricka; Gerhard Rogler; Michael Scharl; Benjamin Misselwitz
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

7.  Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis.

Authors:  Roswitha Siener; Ihsan Machaka; Birgit Alteheld; Norman Bitterlich; Christine Metzner
Journal:  Nutrients       Date:  2020-10-12       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.